osteoporosis semaglutide Effects of and Tirzepatide on Bone Metabolism in Type 2 Diabetic Mice Semaglutide Reduces Risk of Osteoporosis

Tirzepatide (22.5%) and Semaglutide (15%) are both FDA-approved and available today, with Tirzepatide showing superior results and better tolerability than Semaglutide

Small, sustainable shifts such as swapping one red meat meal per week for lentils or fish, or choosing leaner cuts while reducing frequency, may help lower long-term diabetes risk

Here's what we'll cover Here's what we'll cover Here's what we'll cover Key takeaways Insurance plans may stop covering GLP-1s for weight loss due to cost, generic availability, or changes in eligibility criteria

It is approved for long-term use

GLP-1 patches are widely available online, but there is currently no evidence that commercially available patches contain FDA-approved GLP-1 receptor agonist medications, despite what the name implies

This contrasts with compounded GLP-1 options, which are prepared by 503A compounding pharmacies under different regulatory oversight